The Pharmaceutical Contract Manufacturing Market is poised for substantial evolution, anticipated to reach USD 315.91 billion by 2035. This remarkable growth is fueled by a compound annual growth rate (CAGR) of 4.2%, reflecting increasing reliance on contract manufacturers by pharmaceutical firms seeking to optimize production efficiencies. As the global demand for biologics surges, contract...